14th Jun 2021 13:04
Ap19
FORM 8.3 Amendment to purchase
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | Barclays PLC. |
Company dealt in | AON PLC |
Class of relevant security to which the dealings being disclosed relate (Note 2) | ORD |
Date of dealing | 10 JUNE 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Class of relevant security: | ORD | ||||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
544,464 | 0.24% | 1,908,671 | 0.85% | ||
(2) | Derivatives (other than options): | ||||
262,024 | 0.12% | 0 | 0.00% | ||
(3) | Options and agreements to | ||||
purchase/sell: | 24,200 | 0.01% | 24,200 | 0.01% | |
TOTAL: | |||||
830,688 | 0.37% | 1,932,871 | 0.86% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
|
Ap20
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 3 | 247.1400 USD |
Purchase | 6 | 249.0816 USD |
Purchase | 62 | 248.2927 USD |
Purchase | 62 | 248.0427 USD |
Purchase | 91 | 246.8629 USD |
Purchase | 147 | 250.0200 USD |
Purchase | 202 | 248.0174 USD |
Purchase | 232 | 246.5700 USD |
Purchase | 380 | 247.8094 USD |
Purchase | 561 | 248.0042 USD |
Purchase | 600 | 248.6966 USD |
Purchase | 1,085 | 249.7301 USD |
Purchase | 1,188 | 250.0045 USD |
Purchase | 1,300 | 249.6558 USD |
Purchase | 1,495 | 247.6539 USD |
Purchase | 1,827 | 248.5979 USD |
Purchase | 5,917 | 248.8762 USD |
Purchase | 8,482 | 249.0284 USD |
Purchase | 10,017 | 249.4400 USD |
Purchase | 11,900 | 249.8829 USD |
Purchase | 14,226 | 249.7467 USD |
Purchase | 26,369 | 249.2006 USD |
Purchase | 82,169 | 249.8550 USD |
Sale | 1 | 250.1100 USD |
Sale | 6 | 249.0816 USD |
Sale | 15 | 250.1156 USD |
Sale | 52 | 250.0000 USD |
Sale | 52 | 249.9700 USD |
Sale | 52 | 250.0700 USD |
Sale | 52 | 249.9300 USD |
Sale | 52 | 249.8989 USD |
Sale | 62 | 248.2927 USD |
Sale | 70 | 249.8600 USD |
Sale | 100 | 246.3500 USD |
Sale | 100 | 249.9600 USD |
Sale | 100 | 249.2400 USD |
Sale | 100 | 249.7100 USD |
Sale | 100 | 250.0200 USD |
Sale | 101 | 250.0194 USD |
Sale | 131 | 249.9726 USD |
Sale | 167 | 249.9822 USD |
Sale | 173 | 250.1120 USD |
Sale | 200 | 250.1400 USD |
Sale | 232 | 246.5700 USD |
Sale | 246 | 249.9578 USD |
Sale | 279 | 249.3963 USD |
Sale | 300 | 250.3166 USD |
Sale | 310 | 249.9325 USD |
Sale | 356 | 249.9400 USD |
Sale | 500 | 250.3440 USD |
Sale | 511 | 249.4496 USD |
Sale | 518 | 249.8787 USD |
Sale | 560 | 249.9121 USD |
Sale | 756 | 249.6477 USD |
Sale | 1,302 | 249.0553 USD |
Sale | 1,666 | 249.6749 USD |
Sale | 2,000 | 250.0022 USD |
Sale | 2,027 | 248.5742 USD |
Sale | 2,661 | 249.6394 USD |
Sale | 3,586 | 249.4400 USD |
Sale | 3,601 | 249.9774 USD |
Sale | 3,684 | 249.0218 USD |
Sale | 4,814 | 249.0381 USD |
Sale | 5,302 | 249.4386 USD |
Sale | 5,676 | 249.7442 USD |
Sale | 6,568 | 249.8268 USD |
Sale | 7,523 | 249.0006 USD |
Sale | 9,000 | 249.8235 USD |
Sale | 21,994 | 249.9363 USD |
Sale | 27,857 | 249.1571 USD |
Sale | 51,674 | 249.7747 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 attached? (Note 9) YES
Date of disclosure | 14 June 2021 |
Contact name | Large Holdings Regulatory Operations |
Telephone number | 020 3134 7213 |
If a connected EFM, name of offeree/offeror with which connected |
|
If a connected EFM, state nature of connection (Note 10) |
|
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name | Written or | Number of | Exercise | Type | Expiry |
purchased | relevant securities | price | date | ||
to which the option | |||||
or derivative | |||||
relates | |||||
Put Options | Purchased | -1,200 | 220.0000 | American | Jul 16, 2021 |
Call Options | Purchased | 1,200 | 240.0000 | American | Jul 16, 2021 |
Call Options | Purchased | 23,000 | 220.0000 | American | Jul 16, 2021 |
Put Options | Purchased | -23,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210614005408/en/
Copyright Business Wire 2021
Related Shares:
Aon Cl A OrdBarclays